The first institute for personalized medicine or theranostics in Croatia will be opened in Zagreb over the next three years. It will be the third institute of its kind in Europe.
The institute is the result of a recent cooperation agreement between the Croatian Health Ministry and the Swiss pharmaceutical giant Roche, which will invest more than 90 million Kuna into the project.
Dr. Eduard Vrdoljak says that the goal of theranostics is to make cancer a curable disease. "We will be able to save 20 thousand years of live per year. That would mean, let's say, two thousand or one thousand five hundred patients, and with that alone we will make such a big step forward that Croatia will move from the basement to the penthouse in terms of European oncology."
"The idea is to adapt our previous methods of treatment, for which we had no idea how the patient would respond other than knowing that they would have toxicity, to the specific characteristics of each individual tumor, as no two tumors are the same," added Dr. Stjepko Pleština.
- State election commission announces list of presidential candidates
- Final day for submission of candidacies for presidential elections
- Vukovar gets street name in Bratislava
- Opposition to file no-confidence motion against Minister Divjak
- Croatian students do poorly on PISA tests
- 20th anniversary of the death of Franjo Tudjman marked in Split